Moneycontrol
HomeNewsBusinessOver 70% small, medium businesses in India bat for digital shift to weather COVID-19 impact
Trending Topics

Over 70% small, medium businesses in India bat for digital shift to weather COVID-19 impact

Small and medium businesses, in India and across the world, have taken a severe hit due to the coronavirus pandemic-led economic disruption, with many even facing shutdown due to the drastic drop in their revenues amid the lockdowns

September 09, 2020 / 21:29 IST
Story continues below Advertisement
Nearly 75 percent of the respondents in the survey recognised the significance of a switch to digital in order to revive business.

Several small and medium businesses (SMBs) in Asia, especially their Indian counterparts, are batting for adoption of digital tools to weather the COVID-19 impact, a recent report has revealed.

Nearly 75 percent of the respondents in the survey recognised the significance of a switch to digital in order to revive business.

Story continues below Advertisement

The HP Asia SMB Report 2020 highlights that about 73 percent of such businesses in India are confident of recovery in the post-pandemic scenario.

Over 60 percent of the respondents from India also see this period as a good opportunity to revisit and reformulate their business strategy.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show